Role of the CHA₂DS₂-VASc score in predicting hospital stay and 90-day readmission among patients with atrial fibrillation in Syria.

IF 1.4 4区医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL

Journal of International Medical Research Pub Date : 2025-02-01 DOI:10.1177/03000605251314807

Ibrahim Antoun, Alamer Alkhayer, Alkassem Alkhayer, Yaman Mahfoud, Ahmed Kotb, Riyaz Somani, G André Ng, Mustafa Zakkar

{"title":"Role of the CHA2DS2-VASc score in predicting hospital stay and 90-day readmission among patients with atrial fibrillation in Syria.","authors":"Ibrahim Antoun, Alamer Alkhayer, Alkassem Alkhayer, Yaman Mahfoud, Ahmed Kotb, Riyaz Somani, G André Ng, Mustafa Zakkar","doi":"10.1177/03000605251314807","DOIUrl":null,"url":null,"abstract":"Objectives: We assessed the CHA2DS2-VASc score for predicting hospital readmission risk and length of stay (LOS) in patients admitted with primary atrial fibrillation (AF).Methods: This retrospective cohort study included patients with index admission for AF to Latakia's tertiary center (May 2021-November 2023). Patients were followed 90 days to assess readmission. CHA2DS2-VASc was correlated with 90-day readmission, inpatient all-cause mortality, and LOS during index admission.Results: In total, 717 patients were included; 320 (45%) were readmitted to the hospital within 90 days (58% men, 65% aged <65 years). Inpatient mortality was 4%; the median LOS was 2 days. There was an increase in the incident rate ratio (IRR) of LOS starting from a CHA2DS2-VASc of 2 (IRR: 2, 95% confidence interval [CI]: 1.7-2.2) to a score of >6 (IRR: 5, 95% CI: 1.8-10.7), compared with a score of 0. There was an incremental increase in the hazard ratio (HR) of readmission from a score of 1 (HR: 2.3, 95% CI: 1.3-4.1) to a score of >6 (HR: 41, 95% CI: 31-72) compared with a CHA2DS2-VASc of 0.Conclusion: CHA2DS2-VASc could predict 90-day hospital readmission and LOS during the index admission in patients admitted with primary AF.","PeriodicalId":16129,"journal":{"name":"Journal of International Medical Research","volume":"53 2","pages":"3000605251314807"},"PeriodicalIF":1.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11806465/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03000605251314807","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: We assessed the CHA₂DS₂-VASc score for predicting hospital readmission risk and length of stay (LOS) in patients admitted with primary atrial fibrillation (AF).

Methods: This retrospective cohort study included patients with index admission for AF to Latakia's tertiary center (May 2021-November 2023). Patients were followed 90 days to assess readmission. CHA₂DS₂-VASc was correlated with 90-day readmission, inpatient all-cause mortality, and LOS during index admission.

Results: In total, 717 patients were included; 320 (45%) were readmitted to the hospital within 90 days (58% men, 65% aged <65 years). Inpatient mortality was 4%; the median LOS was 2 days. There was an increase in the incident rate ratio (IRR) of LOS starting from a CHA₂DS₂-VASc of 2 (IRR: 2, 95% confidence interval [CI]: 1.7-2.2) to a score of >6 (IRR: 5, 95% CI: 1.8-10.7), compared with a score of 0. There was an incremental increase in the hazard ratio (HR) of readmission from a score of 1 (HR: 2.3, 95% CI: 1.3-4.1) to a score of >6 (HR: 41, 95% CI: 31-72) compared with a CHA₂DS₂-VASc of 0.

Conclusion: CHA₂DS₂-VASc could predict 90-day hospital readmission and LOS during the index admission in patients admitted with primary AF.

查看原文本刊更多论文

CHA2DS2-VASc评分在预测叙利亚房颤患者住院时间和90天再入院中的作用

目的：我们评估CHA2DS2-VASc评分对原发性心房颤动（AF）患者再入院风险和住院时间（LOS）的预测作用。方法：本回顾性队列研究纳入了Latakia三级中心（2021年5月- 2023年11月）因房颤指数入院的患者。随访90天评估再入院情况。CHA2DS2-VASc与入院时90天再入院、住院全因死亡率和LOS相关。结果：共纳入717例患者；320例（45%）患者在90天内再次入院(58%为男性，65%为年龄2DS2-VASc为2 (IRR: 2, 95%可信区间[CI]: 1.7-2.2)，评分为bbbb6 (IRR: 5, 95% CI: 1.8-10.7)，评分为0。再入院的风险比（HR）从1分（HR: 2.3, 95% CI: 1.3-4.1）增加到bbbb6分（HR: 41, 95% CI: 31-72），而CHA2DS2-VASc为0。结论：CHA2DS2-VASc可预测原发性房颤患者入院时90天再入院及LOS。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of International Medical Research 医学-药学

CiteScore

3.20

自引率

0.00%

发文量

555

审稿时长

1 months

期刊介绍： _Journal of International Medical Research_ is a leading international journal for rapid publication of original medical, pre-clinical and clinical research, reviews, preliminary and pilot studies on a page charge basis. As a service to authors, every article accepted by peer review will be given a full technical edit to make papers as accessible and readable to the international medical community as rapidly as possible. Once the technical edit queries have been answered to the satisfaction of the journal, the paper will be published and made available freely to everyone under a creative commons licence. Symposium proceedings, summaries of presentations or collections of medical, pre-clinical or clinical data on a specific topic are welcome for publication as supplements. Print ISSN: 0300-0605